You have 9 free searches left this month | for more free features.

baricitinib

Showing 26 - 50 of 78

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Uveitis Trial in Worldwide (Baricitinib, Adalimumab)

Recruiting
  • Uveitis
  • Nîmes, Gard, France
  • +22 more
Nov 9, 2022

Nakajo-Nishimura Syndrome, Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome,

Active, not recruiting
  • Nakajo-Nishimura Syndrome
  • +3 more
  • Baricitinib
  • Hiroshima-shi, Hiroshima-ken, Japan
  • +4 more
Oct 14, 2021

COVID-19 Pneumonia Trial in Bangladesh (Baricitinib, Dexamethasone, Remdesivir)

Recruiting
  • COVID-19 Pneumonia
  • Baricitinib
  • +2 more
  • Comilla, Bangladesh
  • +6 more
Aug 25, 2021

Molecular Signatures in Inflammatory Skin Disease

Recruiting
  • Atopic Dermatitis
  • Psoriasis
  • Kiel, Germany
    Department of Dermatology, University Hospital Schleswig Holstei
Jul 16, 2022

COVID-19 Trial in Aurora (Baricitinib)

Withdrawn
  • COVID-19
  • Baricitinib
  • Aurora, Colorado
    University of Colorado, Denver
Mar 3, 2021

Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in Los Angeles (Baricitinib, Hydroxychloroquine, Placebo

Terminated
  • Symptomatic COVID-19 Infection Laboratory-Confirmed
  • Baricitinib
  • +2 more
  • Los Angeles, California
  • +1 more
May 21, 2021

Rheumatoid Arthritis, Bone Density, Finger Joints Trial in Erlangen (Baricitinib)

Unknown status
  • Rheumatoid Arthritis
  • +2 more
  • Baricitinib
  • Erlangen, Bavaria, Germany
    Universitiy Hospital Erlangen
Jan 14, 2021

Covid19, Covid-19 ARDS Trial in Dinajpur (Remdesivir, Baricitinib, Tocilizumab)

Recruiting
  • Covid19
  • Covid-19 ARDS
  • Dinajpur, Bangladesh
    M. Abdur Rahim Medical College Hospital
Dec 31, 2020

Systemic Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib, Placebo)

Recruiting
  • Systemic Juvenile Idiopathic Arthritis
  • Baricitinib
  • Placebo
  • Rosario, Santa Fe, Argentina
  • +65 more
Jan 18, 2023

Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)

Recruiting
  • Rheumatoid Arthritis
  • Omaha, Nebraska
    University of Nebraska Medical Center
Oct 28, 2021

Rheumatoid Arthritis Trial in United States (Active Stimulation, Sham Stimulation, Baricitinib)

Recruiting
  • Rheumatoid Arthritis
  • Active Stimulation
  • +3 more
  • Anniston, Alabama
  • +3 more
Oct 25, 2021

Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE), Juvenile Dermatomyositis (JDM),

No longer available
  • Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE)
  • +3 more
  • Baricitinib
  • Bethesda, Maryland
  • +2 more
Apr 6, 2022

Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo, Topical corticosteroid)

Recruiting
  • Atopic Dermatitis
  • Baricitinib
  • +2 more
  • Caba, Buenos Aires, Argentina
  • +85 more
Nov 4, 2022

Atopic Dermatitis Trial in Canada, Puerto Rico, United States (Baricitinib)

Completed
  • Atopic Dermatitis
  • Baricitinib
  • Birmingham, Alabama
  • +73 more
Jul 22, 2022

Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib, Placebo)

Completed
  • Juvenile Idiopathic Arthritis
  • Baricitinib
  • Placebo
  • Rosario, Santa Fe, Argentina
  • +85 more
Sep 8, 2022

Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib)

Recruiting
  • Juvenile Idiopathic Arthritis
  • Baricitinib
  • Rosario, Santa Fe, Argentina
  • +95 more
Jan 18, 2023

Rheumatoid Arthritis Trial in United States (Baricitinib, TNF Inhibitor)

Recruiting
  • Rheumatoid Arthritis
  • Baricitinib
  • TNF Inhibitor
  • Flagstaff, Arizona
  • +108 more
Jan 17, 2023

Primary Biliary Cholangitis Trial in Puerto Rico, United States (Baricitinib, Placebo)

Terminated
  • Primary Biliary Cholangitis
  • Baricitinib
  • Placebo
  • Coronado, California
  • +11 more
Sep 18, 2020

Alopecia Areata Trial in Worldwide (Baricitinib, Placebo)

Active, not recruiting
  • Alopecia Areata
  • Baricitinib
  • Placebo
  • Birmingham, Alabama
  • +74 more
Feb 2, 2022

Pharmacological Action Trial in Prato (Baricitinib)

Unknown status
  • Pharmacological Action
  • Baricitinib
  • Prato, Tuscany, Italy
    Fabrizio Cantini
Apr 19, 2020

Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo, Topical corticosteroid)

Active, not recruiting
  • Atopic Dermatitis
  • Baricitinib
  • +2 more
  • Graz, Steiermark, Austria
  • +102 more
May 25, 2022

Alopecia Areata Trial in Worldwide (Baricitinib, Placebo)

Active, not recruiting
  • Alopecia Areata
  • Baricitinib
  • Placebo
  • Birmingham, Alabama
  • +97 more
Jan 24, 2022

Atopic Dermatitis Trial in Canada, Puerto Rico, United States (Baricitinib, Placebo)

Completed
  • Atopic Dermatitis
  • Baricitinib
  • Placebo
  • Birmingham, Alabama
  • +80 more
Aug 17, 2021

Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo)

Active, not recruiting
  • Atopic Dermatitis
  • Baricitinib
  • Placebo
  • Caba, Buenos Aires, Argentina
  • +184 more
Jun 7, 2022